Josef H. von Rickenbach, who serves as a director at Rein Therapeutics, Inc., recently engaged in several open market purchases of the company's common stock. These transactions resulted in Mr. von Rickenbach acquiring shares valued at $49,560.
The accumulation of these shares took place over multiple days during late May 2026. Notably, the timing of these acquisitions coincided with a period of significant upward movement for the company's stock. According to data provided by InvestingPro, Rein Therapeutics shares gained nearly 8% in the week leading up to and including the reporting period.
Detailed Breakdown of Transactions
Between May 21 and May 27, 2026, Mr. von Rickenbach purchased a combined total of 47,060 shares of Rein Therapeutics common stock. The cost basis for these purchases varied daily, with the weighted average prices falling within a range from $1.0422 to $1.0708 per share.
A granular look at the acquisition dates reveals the following pattern: On May 21, 2026, he acquired 3,420 shares. This was followed by a purchase of an additional 15,950 shares on May 22, 2026. Further buying activity included 23,190 shares secured on May 26, 2026, and a final reported acquisition of 4,500 shares on May 27, 2026.
The specific purchase price ranges for these different days also varied. On May 21, transactions occurred within the $1.035 to $1.05 range. Prices on May 22 were observed between $1.01 and $1.07. For May 26, the transaction prices spanned $1.03 to $1.07. Finally, on May 27, the purchase prices ranged from $1.03 to $1.08.
Following these reported transactions, Mr. von Rickenbach currently holds a total of 62,514 shares of Rein Therapeutics common stock. As of the reporting period, the company's stock was trading at $1.11 per share, carrying an associated market capitalization of $104 million.
Risks
- <p><strong>Valuation Concerns:</strong> InvestingPro analysis indicates that the stock may be overvalued relative to its Fair Value estimate, and the platform's Financial Health score is rated as "WEAK," suggesting potential financial instability or valuation risk for investors.</p>
- <p><strong>Market Volatility/Timing:</strong> The transactions occurred during a period of significant stock gains (nearly 8% in one week), which could imply market enthusiasm but also heightened volatility, presenting timing risks for future investments.</p>
More from Insider Trading